v3.21.2
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Mar. 31, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Cash Flow From Operating Activities              
Net loss $ (2,343) $ (2,633) $ (2,438) $ 1,169 $ (7,175) $ (5,297)  
Adjustments to reconcile net loss to net cash used in operating activities:              
Depreciation expense         119 54 $ 100
Amortization of right of use asset         331 310  
Amortization of intangible assets         3 4  
Non-cash interest income         (88) (242)  
Stock based compensation         220 29  
Change in fair value of derivative liabilities (481)   287   (225) (1,750)  
Offering costs         325  
Gain on disposal of equipment         (144)  
Forgiveness of PPP loan     (391)  
Changes in operating assets and liabilities:              
Trade accounts receivable         (140) 87  
Prepaid expenses and other current assets         (177) (73)  
Inventories         (203) 104  
Accounts payable and accrued liabilities         417 (353)  
Payments on operating lease liability         (294) (254)  
Net cash used in operating activities         (7,747) (7,056)  
Cash Flows From Investing Activities              
Purchase of property and equipment         (3,210) (150)  
Proceeds from notes receivable, net of imputed interest         1,944 1,528  
Proceeds from sale of property and equipment         144  
Net cash provided by (used in) investing activities         (1,122) 1,378  
Cash Flows From Financing Activities              
Proceeds from issuance of preferred stock         3,112  
Proceeds from issuance of warrant derivative liabilities         6,328  
Proceeds from issuance of common stock, net of fees         20,015  
Proceeds from issuance of common stock in connection with exercise of warrants         196 1,109  
Proceeds from issuance of debt         510 406  
Payments on debt         (5) (29)  
Net cash provided by financing activities         701 30,941  
Net increase (decrease) in cash and cash equivalents         (8,168) 25,263  
Cash and cash equivalents at beginning of period   $ 25,351   $ 1,787 25,351 1,787 1,787
Cash and cash equivalents at end of period $ 17,183   $ 27,050   17,183 27,050 $ 25,351
Noncash Investing and Financing Activities              
Right-of-Use Assets and assumption of operating lease liability         918  
Extinguishment of derivative liabilities through exercise of warrants         195 3,197  
Change in par value due to conversion of preferred stock to common stock         65  
Issuance of common stock for the cashless exercise of warrants         35  
Supplemental Cash Flow Information              
Cash paid for interest         $ 2  

Source